Vanda Pharmaceuticals Inc. Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Vanda Pharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Vanda Pharmaceuticals Inc. Return On Equity for the quarter ending September 30, 2024 was -3.02 %, a 237% decline year-over-year.
  • Vanda Pharmaceuticals Inc. annual Return On Equity for 2023 was 0.46 %, a 62.2% decline from 2022.
  • Vanda Pharmaceuticals Inc. annual Return On Equity for 2022 was 1.22 %, a 82.1% decline from 2021.
  • Vanda Pharmaceuticals Inc. annual Return On Equity for 2021 was 6.81 %, a 27.1% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -3.02 -5.21 -237% Jul 1, 2024 Sep 30, 2024
Q2 2024 -2.01 -4.82 -171% Apr 1, 2024 Jun 30, 2024
Q1 2024 -0.9 -3.96 -129% Jan 1, 2024 Mar 31, 2024
Q4 2023 0.46 -0.76 -62.2% Oct 1, 2023 Dec 31, 2023
Q3 2023 2.19 +0.92 +72% Jul 1, 2023 Sep 30, 2023
Q2 2023 2.81 +0.63 +28.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 3.06 -0.59 -16.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 1.22 -5.59 -82.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 1.28 -5.95 -82.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 2.19 -4.85 -68.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 3.65 -3.38 -48.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 6.81 +1.45 +27.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 7.23 +2.67 +58.6% Jul 1, 2021 Sep 30, 2021
Q2 2021 7.04 -20.4 -74.3% Apr 1, 2021 Jun 30, 2021
Q1 2021 7.03 -23.6 -77% Jan 1, 2021 Mar 31, 2021
Q4 2020 5.36 -28 -83.9% Oct 1, 2020 Dec 31, 2020
Q3 2020 4.56 -34.3 -88.3% Jul 1, 2020 Sep 30, 2020
Q2 2020 27.4 +17.2 +168% Apr 1, 2020 Jun 30, 2020
Q1 2020 30.6 +22.5 +279% Jan 1, 2020 Mar 31, 2020
Q4 2019 33.3 +23.5 +240% Oct 1, 2019 Dec 31, 2019
Q3 2019 38.9 +33 +562% Jul 1, 2019 Sep 30, 2019
Q2 2019 10.2 +9.55 +1397% Apr 1, 2019 Jun 30, 2019
Q1 2019 8.07 +11.1 Jan 1, 2019 Mar 31, 2019
Q4 2018 9.8 +21.7 Oct 1, 2018 Dec 31, 2018
Q3 2018 5.88 +16.9 Jul 1, 2018 Sep 30, 2018
Q2 2018 0.68 +8.54 Apr 1, 2018 Jun 30, 2018
Q1 2018 -3.06 +7.36 +70.6% Jan 1, 2018 Mar 31, 2018
Q4 2017 -11.9 +2.32 +16.3% Oct 1, 2017 Dec 31, 2017
Q3 2017 -11 +14.4 +56.7% Jul 1, 2017 Sep 30, 2017
Q2 2017 -7.86 +23.7 +75.1% Apr 1, 2017 Jun 30, 2017
Q1 2017 -10.4 +20 +65.8% Jan 1, 2017 Mar 31, 2017
Q4 2016 -14.3 +13.2 +48% Oct 1, 2016 Dec 31, 2016
Q3 2016 -25.4 -54.7 -187% Jul 1, 2016 Sep 30, 2016
Q2 2016 -31.5 -76.9 -169% Apr 1, 2016 Jun 30, 2016
Q1 2016 -30.5 -76.8 -166% Jan 1, 2016 Mar 31, 2016
Q4 2015 -27.4 -71.4 -162% Oct 1, 2015 Dec 31, 2015
Q3 2015 29.3 +371 Jul 1, 2015 Sep 30, 2015
Q2 2015 45.4 +257 Apr 1, 2015 Jun 30, 2015
Q1 2015 46.3 +190 Jan 1, 2015 Mar 31, 2015
Q4 2014 43.9 +124 Oct 1, 2014 Dec 31, 2014
Q3 2014 -342 -231 -210% Jul 1, 2014 Sep 30, 2014
Q2 2014 -211 +1.96 +0.92% Apr 1, 2014 Jun 30, 2014
Q1 2014 -143 +43.6 +23.3% Jan 1, 2014 Mar 31, 2014
Q4 2013 -79.7 +73.4 +47.9% Oct 1, 2013 Dec 31, 2013
Q3 2013 -110 +1.73 +1.55% Jul 1, 2013 Sep 30, 2013
Q2 2013 -213 -130 -156% Apr 1, 2013 Jun 30, 2013
Q1 2013 -187 -135 -259% Jan 1, 2013 Mar 31, 2013
Q4 2012 -153 Oct 1, 2012 Dec 31, 2012
Q3 2012 -112 Jul 1, 2012 Sep 30, 2012
Q2 2012 -83.2 Apr 1, 2012 Jun 30, 2012
Q1 2012 -52 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.